The influence of causation and effectuation logics on targeted policies: The cases of Singapore and Israel

Technology Analysis and Strategic Management

Volumn 25, Issue 7, 2013, Pages 853-870

  Kaufmann, Dan ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

biotechnology; causation and effectuation; innovation policies; targeting

Indexed keywords

BIOTECHNOLOGY; CLUSTER ANALYSIS; ENTREPRENEUR; INNOVATION; KNOWLEDGE; POLICY IMPLEMENTATION; TECHNOLOGY POLICY;

ISRAEL; SINGAPORE [SINGAPORE (NTN)]; SINGAPORE [SOUTHEAST ASIA];

EID: 84882246971     PISSN: 09537325     EISSN: 14653990     Source Type: Journal    
DOI: 10.1080/09537325.2013.815714     Document Type: Article

References (39)

1. Aviv, H. 2007. Bio-Israel infrastructures - Program for national infrastructures. Report submitted to Israel's Forum for National Infrastructures for Research & Development (TELEM), July 2007.
2. Avnimelech, G. 2013. Targeting the biotechnology clusters in North Carolina and Israel: Lessons from successful and unsuccessful policy making. Technology Analysis & Strategic Management, 25 000-00 (this issue).
3. Avnimelech, G. and Teubal, M. 2008. Evolutionary targeting. Journal of Evolutionary Economics, 18: 151 - 66. (doi:10.1007/s00191-007-0080-6)
4. Avnimelech, G. and Teubal, M. 2010. " The co-evolution of ICT, VC and policy in Israel during the 1990s ". In Emerging clusters: Theoretical empirical and political perspectives on the initial state of cluster evolution, Edited by: Fornahal, D., Henn, S. and Menzel, M. P. 140 - 60. Cheltenham, UK: Edward Elgar.
5. Bizan, O. 2003. The determinants of success of R&D projects: Evidence from American-Israeli research alliances. Research Policy, 32: 1619 - 40. (doi:10.1016/S0048-7333(03)00044-1)
6. Brettel, M., Mauer, R., Engelen, A. and Küpper, D. 2012. Corporate effectuation: Entrepreneurial action and its impact on R&D project performance. Journal of Business Venturing, 27: 167 - 84. (doi:10.1016/j.jbusvent.2011.01.001)
7. Breznitz, D. 2007. Innovation and the state, New Haven, CT: Yale: University Press.
8. Chaturvedi, S. 2005. Evolving national system of biotechnology innovation: Some evidence from Singapore. Science Technology and Society, 10: 104 - 27. (doi:10.1177/097172180401000106)
9. Cooke, P. 2004. The accelerating evolution of biotechnology clusters. European Planning Studies, 12: 915 - 20. (doi:10.1080/0965431042000267821)
10. Cooke, P. 2007. Growth cultures: The global bioeconomy and its bioregions, London: Routledge.
11. Duncan, R. B. 1976. " The ambidextrous organization: Designing dual structures for innovation ". In The management of organization, Edited by: Kilmann, I. R.H., Pondy, L. R. and Slevin, D. 167 - 88. New York: North-Holland.
12. Finegold, D., Wong, P. K. and Cheah, T. C. 2004. Adapting a foreign direct investment strategy to the knowledge economy: The case of Singapore's emerging biotechnology cluster. European Planning Studies, 12: 921 - 41. (doi:10.1080/0965431042000267830)
13. GlenRock. 2007. The biotechnology industry in Israel - A national missed opportunity. Report submitted to the Chief Scientist at the Ministry of Industry and Trade, Tel Aviv, May 2007.
14. Hausmann, R., Rodrik, D. and Sabel, C. 2008. Reconfiguring industrial policy: A framework with an application to South Africa. CID Working Paper 168, Centre for International Development Harvard University, Cambridge, MA.
15. Katsnelson, A. 2005. When will Israeli biotech grow up?. Nature Biotechnology, 23: 1337
16. Katzir, A. 1988. Policy to enhance biotechnology R&D in Israel. The National Biotechnology Committee, Israel (in Hebrew).
17. Katzir, A., and M. Herzberg. 1992. Biotechnology progress report. The National Biotechnology Committee, Israel (in Hebrew).
18. Kaufmann, D., and O. Gore. 2009. An evaluation of the Israeli Incubator Program. The Jerusalem Institute for Israel Studies.
19. Kaufmann, D. and Levin, C. 2002. An analysis of the Jerusalem biotechnology and software clusters. The Jerusalem Institute for Israel Studies.
20. Kaufmann, D. and Schwartz, D. 2008. Networking strategies of young biotechnology firms. Annals of Regional Science, 43: 599 - 613. (doi:10.1007/s00168-008-0253-8)
21. Kaufmann, D., Schwartz, D., Frenkel, A. and Shefer, D. 2003. The role of location and regional networks for biotechnology firms in Israel. European Planning Studies, 11: 823 - 40. (doi:10.1080/0965431032000121364)
22. Lall, S. and Teubal, M. 1998. 'Market-stimulating' technology policies in developing countries: A framework with examples from East Asia. World Development, 26: 1369 - 85. (doi:10.1016/S0305-750X(98)00071-0)
23. Lord, Sainsbury. 1999. " Biotechnology clusters ". London: Department of Trade and Industry.
24. Malerba, F. and Nelson, R. R. 2012. Economic development as a learning process: Variation across sectoral systems, Cheltenham, UK: Edward Elgar.
25. Meser-Yaron, H. 2001. " National priority to biotechnology ". Israel: Science Ministry Think Tank.
26. Ministry of Trade and Industry (Singapore). 2003. New challenges, fresh goals: Towards a dynamic global city, Singapore: SNP SPrint.
27. Monitor. 2001. Realizing our potential - Israeli biotechnology strategy project. Report submitted to the Chief Scientist at the Ministry of Industry and Trade, the Ministry of Finance and to Israel Biotechnology Organization, January 2001.
28. Nill, J. and Kemp, R. 2009. Evolutionary approaches for sustainable innovation policies: From niche to paradigm?. Research Policy, 38: 668 - 80. (doi:10.1016/j.respol.2009.01.011)
29. OECD. 2001. Boosting innovation the cluster approach, Paris: OECD.
30. Okamoto, Y. 2009. Creating a biotechnology cluster: Lessons to learn from Singapore's experience. Doshisha University Policy Studies no. 3 (March).
31. Sandstrom, A. 2009. Aiming to create the Biopolis of Asia, Sweden: Vinova Analysis. (Series VA 2009:13).
32. Sarasvathy, D. S. 2001. Causation and effectuation: Towards a theoretical shift from economic inevitability to entrepreneurial contingency. Academy of Management Review, 26: 243 - 88.
33. Sarasvathy, D. S. 2008. Effectuation - Elements of entrepreneurial expertise, Northhampton, MA: Edward Elgar.
34. Shahid, Y. and Nabeshima, K. 2006. Postindustrial East Asian cities: Innovation for growth, Stanford, CA and Washington, DC: Stanford University Press and the World Bank.
35. Teubal, M. 1997. A catalytic and evolutionary approach to horizontal technology policies (HTPs). Research Policy, 25: 1161 - 88. (doi:10.1016/S0048-7333(96)00886-4)
36. Trajtenberg, M. 2002. " Government support for commercial R&D: Lessons from the Israeli experience ". In Innovation policy and the economy, Edited by: Jaffe, A. B., Lerner, J. and Stern, S. Vol. 2, 79 - 134. Cambridge, MA: MIT Press.
37. Weiss, J. 2011. Industrial policy in the twenty-first century. World Institute for Development Economics Research, Working paper No. 2011/55. http://hdl.handle.net/10419/54116.
38. Wong, P. K. 2006. Commercializing biomedical science in a rapidly changing 'triple-helix' nexus: The experience of the National University of Singapore. The Journal of Technology Transfer, 32: 367 - 95. (doi:10.1007/s10961-006-9020-0)
39. Zhang, F., Cooke, P. and Wu, F. 2011. State-sponsored R&D: A case study of China's biotechnology. Regional Studies, 45: 575 - 95. (doi:10.1080/00343401003604663)